Literature DB >> 6512440

Computerization of a nosocomial infection system.

S Etersque, M J Carter, K R Gordon, J G Sutherland.   

Abstract

This paper describes the implementation of a computerized nosocomial infection control system for a 500-bed tertiary-care teaching hospital. It is implemented on a minicomputer that uses the relational data base management system INGRES, which is marketed by Relational Technology, Inc. This system, which replaces a manual one that depended on "needle sort" data cards, is designed to provide for entry of infection data that have been collected onto abstracting forms; decision support in the prospective analysis of suspicious infection rates or trends; generation of monthly, on-demand, and annual infection rate reports; retrospective interrogation and analysis of infection data for rates and trends that may explain or clearly indicate the sources of in-hospital (nosocomial) infections; updating of infection records as additional infection-related data become available and known to the hospital's infection control team; and ad hoc analysis and comparisons between data on control and infected patients, both prospectively and retrospectively.

Entities:  

Mesh:

Year:  1984        PMID: 6512440     DOI: 10.1007/bf02285253

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  3 in total

1.  The emergence of infection surveillance and control programs in US hospitals: an assessment, 1976.

Authors:  R W Haley; R H Shachtman
Journal:  Am J Epidemiol       Date:  1980-05       Impact factor: 4.897

2.  A method for classifying patients according to the nosocomial infection risks associated with diagnoses and surgical procedures.

Authors:  T M Hooton; R W Haley; D H Culver
Journal:  Am J Epidemiol       Date:  1980-05       Impact factor: 4.897

3.  Progress report on the evaluation of the efficacy of infection surveillance and control programs.

Authors:  R W Haley; D H Culver; T G Emori; T M Hooton; J W White
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.